Education
About Us
Working with TipRanks
Follow Us
Agenus Inc. (AGEN)
:AGEN
Earnings Data
Report Date
Nov 11, 2025Before Open (Confirmed)
Period Ending
2025 (Q3)Consensus EPS Forecast
2.2Last Year’s EPS
-3.08Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The earnings call highlighted several positive developments, including strategic hires, promising BOT/BAL data, and multiple capital proposals which could strengthen the company's financial position. However, financial metrics such as a decreased cash balance and lower revenue compared to the previous year, alongside ongoing regulatory challenges, present notable challenges. The overall sentiment is cautiously optimistic as the highlights and lowlights are balanced.Company Guidance
Operational Efficiency Goals
Agenus is on track to reduce its operational cash burn to below $50 million annualized in the second half of 2025.
New Leadership and Strategic Hire
Dr. Richard Goldberg, a GI-Oncology expert, joined as Chief Development Officer to advance regulatory filings in metastatic colorectal cancer and other tumor types.
Promising BOT/BAL Data
New BOT/BAL data shows durable responses in cold tumors, including MSS colorectal cancer, with deep and durable disease control demonstrated in heavily pre-treated liver cancer patients.
Strategic Capital Proposals
Agenus received four formal transaction proposals, including the sale of the Emeryville facility, a significant equity investment at a premium, and two licensing deals for BOT/BAL.
Regulatory Environment Shift
Changes in FDA policies may favor rapid approval of transformative therapies, aligning with Agenus' goals for BOT/BAL's accelerated approval.
AGEN Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
AGEN Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Aug 11, 2025 | $4.80 | $4.27 | -11.04% |
May 12, 2025 | $2.91 | $3.50 | +20.27% |
Mar 11, 2025 | $2.15 | $2.05 | -4.65% |
Nov 12, 2024 | $3.90 | $3.10 | -20.51% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Agenus Inc. (AGEN) report earnings?
Agenus Inc. (AGEN) is schdueled to report earning on Nov 11, 2025, Before Open (Confirmed).
What is Agenus Inc. (AGEN) earnings time?
Agenus Inc. (AGEN) earnings time is at Nov 11, 2025, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is AGEN EPS forecast?
AGEN EPS forecast for the fiscal quarter 2025 (Q3) is 2.2.